Enzyme USP15 Identified as Potential Target for Ovarian Cancer Treatment
Medical Xpress1 min read94 words
Ovarian cancer is frequently diagnosed after it has metastasized to other parts of the body, a stage associated with a five-year survival rate of under 30%. Current standard therapies for this condition are complicated by their tendency to cause substantial harm to healthy cells in addition to cancerous ones. The enzyme USP15 has been identified as a promising new target for treating ovarian cancer.
This potential new approach aims to allow for more specific targeting of cancerous cells, which could result in less harm to the rest of the body compared to existing treatments.
Read the original at Medical Xpress
🤖 AI-generated content — This article was automatically summarised from public RSS feeds by AutoBrief. Verify important information with the original source.